http://sandiego.jobing.com/
AutoGenomics, Inc., a privately held company based in Carlsbad, CA has developed one of the first automated microarray based multiplexing molecular diagnostic platforms that can be used to assess disease signatures with novel genomic and proteomic markers in the area of genetic disorders, infectious diseases, cancer and pharmacogenetics. With discovery of genes and their link to various disease states the platform has the versatility to revolutionize the way patients are diagnosed, monitored and managed, leading to the new era of personalized medicine.
Link to this comment:
All Comments (0)